Search Results for "Clia 82486"
Original Source: Effects of Short-term Growth Hormone in HIV-infected Patients
The purpose of this study is to examine the short-term effects of two different doses of growth hormone on the brain's secretion of growth hormone and the body's glucose metabolism. We hypothesize that growth hormone administration will alter the body's endogenous pulsatile growth hormone secretion and that higher dose growth hormone may decrease insulin sensitivity.
Matching Channels
None
Matching News
Genewiz obtains CLIA certification
Genewiz, a provider of DNA services, has obtained clinical laboratory improvement amendments (CLIA) certification.
Roche Says FDA Grants CLIA-waived Status To CoaguChek XS Plus System
SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY.PK) announced Monday that the U.S. Food and Drug Administration or FDA has granted CLIA-waived status to the CoaguChek XS Plus system, a point-of-care ...
MDxHealth’s Irvine, California and CLIA laboratory receive CAP accreditation
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced that the company's Irvine, California, CLIA laborato...
EMD Millipore contract research laboratory obtains CLIA certification
EMD Millipore has obtained Clinical Laboratory Improvement Amendments (CLIA) certification for its contract research laboratory located in St Louis for drug discovery and development services.
MDxHealth wins ISO certification for CLIA laboratory in Irvine, US
DEKRA Certification has awarded ISO 9001:2008 certification to MDxHealth's CLIA certified and College of American Pathologists (CAP) accredited laboratory in Irvine, California, US.
Sequenta LymphoSIGHT based clinical test wins CLIA certification
Sequenta has obtained clinical laboratory improvement amendments (CLIA) certification for its new clinical test, which is based on the LymphoSIGHT method.
Opening a CLIA (Clinical Laboratory Improvement Amendments) Certified Laboratory
CLIA (Clinical Laboratory Improvement Amendments) passed by Congress in 1988 (Federal Register, 1992), is an increasingly key requirement for clinical research laboratories that provide human-derived...
Chembio Commences CLIA Waiver Studies for DPP(R) HIV 1/2 Assay
MEDFORD, N.Y., April 18, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI) a leader in point-of-care diagnostic tests ("POCT"), announces that the Clinical Laboratory Improvement Amend...
Matching PubMed Articles
In this paper, chemiluminescence immunoassay (CLIA) was introduced into the recently proposed microfluidic paper-based analytical devices (μPADs) through covalent fabrication strategy for the first t...
Serum HER2 levels determined by two methods in patients with metastatic breast cancer.
BACKGROUND: The role and the optimal measurement method of serum HER2 levels are not defined in patients with metastatic breast cancer (MBC). We prospectively assessed the prognostic value of serum HE...
A novel highly sensitive chemiluminescence immunoassay (CLIA) was developed to detect zearalenone in food samples by using both biotinylated zearalenone conjugates and gold (Au) nanoparticles labeled...
Biochemical genetic testing and newborn screening are essential laboratory services for the screening, detection, diagnosis, and monitoring of inborn errors of metabolism or inherited metabolic disord...
Because squamous cell carcinoma antigen (SCCa) quantification has demonstrated strong clinical potential, we describe a rapid and highly sensitive magnetic particle-based chemiluminescence immunoassay...
